KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Nu Skin Enterprises (NUS) EBIAT (2016 - 2025)

Nu Skin Enterprises (NUS) has disclosed EBIAT for 17 consecutive years, with $14.5 million as the latest value for Q4 2025.

  • Quarterly EBIAT rose 140.14% to $14.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $160.2 million through Dec 2025, up 209.28% year-over-year, with the annual reading at $160.2 million for FY2025, 209.28% up from the prior year.
  • EBIAT hit $14.5 million in Q4 2025 for Nu Skin Enterprises, down from $17.1 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $107.5 million in Q1 2025 to a low of -$118.3 million in Q2 2024.
  • Historically, EBIAT has averaged $13.7 million across 5 years, with a median of $15.8 million in 2025.
  • Biggest five-year swings in EBIAT: crashed 595.81% in 2024 and later surged 20271.67% in 2025.
  • Year by year, EBIAT stood at -$9.2 million in 2021, then skyrocketed by 719.81% to $57.2 million in 2022, then tumbled by 87.27% to $7.3 million in 2023, then plummeted by 595.81% to -$36.1 million in 2024, then skyrocketed by 140.14% to $14.5 million in 2025.
  • Business Quant data shows EBIAT for NUS at $14.5 million in Q4 2025, $17.1 million in Q3 2025, and $21.1 million in Q2 2025.